For reliable Western blot results, we recommend choosing antibodies with documented WB validation, matching host species and isotype to the sample, favouring monoclonal or recombinant formats for specificity, and confirming that any loading control remains stable under the experimental conditions used, with total protein staining as a frequent alternative. Supplier validation data should always be followed by an in-lab verification step before any antibody is used for quantification.
TL;DR:
- Knockout or knockdown cell lines offer strong evidence that a band represents the intended target; without them, compare independent antibodies or use mass spectrometry.
- Polyclonal antibodies can detect proteins present at low levels by recognizing multiple epitopes, while recombinant formats improve consistency across production lots.
- Check control stability under each treatment, since beta actin, GAPDH, and tubulin can shift; total protein staining avoids dependence on one protein.
- Chemiluminescence suits faint targets, whereas fluorescent secondaries support multiplexing and a wider quantitative range; directly conjugated primaries simplify panels but may reduce sensitivity.
- Run positive and negative controls, test small antibody dilution steps, record lot numbers, and keep optimized settings constant; without genetic controls, confirm results independently.
Table of Contents
- 1. Choosing primary antibodies for western blot
- 2. Selecting internal controls and when to use total protein staining
- 3. Secondary antibodies and detection method considerations
- 4. Validation checklist and in-lab tests
- 5. Why validation-first selection reduces wasted experiments
- How ABMIUM supports antibody selection and validation
- FAQ
- Sources
1. Choosing primary antibodies for western blot
The starting point for any Western blot is confirming that a candidate antibody has documented validation for the WB application itself, rather than for immunohistochemistry or flow cytometry alone. Validation evidence drawn from knockout or knockdown cell lines gives the strongest confidence that a band corresponds to the intended target, and a consensus platform for antibody characterisation recommends these controls as part of transparent reporting practice.
Clonality shapes how an antibody behaves on a blot. Monoclonal antibodies give high lot-to-lot consistency because they recognise a single epitope, while polyclonal antibodies often detect low-abundance proteins more readily through multiple epitope recognition, according to a review of antibody selection and validation. Recombinant antibodies, produced from a defined genetic sequence, tend to offer the most reproducible performance across batches, which matters when a study spans several antibody lots. A deeper comparison of these formats is available in our guide to monoclonal versus polyclonal antibodies.
Species and isotype compatibility deserve equal attention. The antibody’s host species, its target species reactivity and its isotype all need to match the experimental sample and the planned secondary antibody. Because SDS-PAGE denatures proteins, an antibody suited to Western blot must recognise a linear epitope rather than a conformational one, a distinction worth checking before purchase.
- Confirm the antibody is validated specifically for WB, not only for other applications.
- Choose monoclonal or recombinant formats when reproducibility across experiments matters most.
- Check host species, target reactivity and isotype against your sample and secondary antibody.
- Decide between unconjugated and directly conjugated primaries based on sensitivity needs and any multiplexing plans.
- Record catalogue and lot numbers for every antibody used, particularly where validation data varies between batches.
Pro Tip: Keep a running log of catalogue and lot numbers alongside each blot image, since antibody performance can shift between production lots even for the same product.
2. Selecting internal controls and when to use total protein staining
Loading controls exist to confirm equal sample loading, but a poorly chosen one can distort results rather than correct for them. Five criteria help narrow the choice.
- Match the species of the loading control antibody to the species of your sample.
- Choose a control protein with a molecular weight well separated from your target, to avoid overlapping bands.
- Confirm the control occupies the same subcellular compartment as the protein under study.
- Select a reasonably abundant target so the control signal remains detectable at low total protein loads.
- Verify that the control’s expression stays stable across your experimental treatments, rather than assuming stability.
Housekeeping proteins such as beta-actin, GAPDH and tubulin remain common choices, but their expression can shift under certain treatments, disease states or cell stresses. Total protein staining, using Ponceau S or comparable dyes, offers a broader dynamic range and reduces both technical and biological variation compared with a single housekeeping protein, as a review on total protein staining as a loading control notes. Some reviews now recommend total protein staining over single housekeeping proteins for many quantitative Western blot applications, according to this comparison of loading control methods, because it avoids reliance on any single protein’s expression behaviour.
A short practical test can confirm stability before committing to a control: run the candidate control across every treatment condition in the study and check that its signal intensity stays flat relative to total protein. For quantitative comparisons, a statistical analysis of Western blot normalisation suggests treating the loading control value as a covariate, for example through ANCOVA, often produces more robust hypothesis testing than simple ratio normalisation against a single control band.
3. Secondary antibodies and detection method considerations
Once a primary antibody is selected, the secondary antibody and detection chemistry need to match it precisely. The secondary must target the correct host species and isotype of the primary, and preadsorbed secondaries reduce cross-reactivity when working with samples from multiple species or in multiplex panels.
Detection chemistry involves a trade-off. Horseradish peroxidase with chemiluminescence gives high sensitivity for faint targets, while fluorescent secondaries support multiplexing and offer a wider linear dynamic range for quantitative work. Directly conjugated primary antibodies skip the secondary step entirely, which can simplify multiplex panels but usually costs some sensitivity compared with indirect detection.
- Match secondary host species and isotype exactly to the primary antibody in use.
- Use preadsorbed secondaries when working across multiple species or in multiplex formats.
- Choose chemiluminescent detection for maximum sensitivity on low-abundance targets.
- Choose fluorescent secondaries when multiplexing or when quantitative linearity matters.
- Avoid using two primaries raised in the same host species within one multiplex panel, since secondaries cannot distinguish between them.
Blocking buffer choice also affects outcomes: some antibodies show altered nonspecific binding depending on whether milk or BSA-based blocking is used, so it pays to keep this constant once a protocol is working, as noted in the antibody validation guidance referenced below.
4. Validation checklist and in-lab tests
Supplier documentation is a starting point, not a substitute for in-lab confirmation. A stepwise approach keeps this manageable.
- Step 1: Confirm the supplier’s WB validation data, including any knockout or knockdown evidence, before purchase.
- Step 2: Run positive and negative controls alongside a recombinant protein standard where one is available.
- Step 3: Perform a micro-titration series to identify the antibody dilution that gives the cleanest signal-to-noise ratio.
- Step 4: Document band size, lot numbers and any validation images for future reference.
Assay context strongly influences antibody performance, so user-driven validation guidance recommends assay-specific verification with clear reporting of lot numbers and control conditions, rather than relying solely on data generated in a different buffer system or sample type. Once a dilution and transfer protocol are optimised, keeping those parameters constant across subsequent experiments preserves comparability between blots, a point covered further in our western blot protocol guide.
When knockout or knockdown controls are not available for a given target, orthogonal validation, such as correlating results with mass spectrometry or using a second independent antibody against a different epitope, offers a reasonable substitute. For targets that resist straightforward in-house validation, our ABMIUM MATCH™ service and Product Validation Service provide scientist-led support for comparing candidate antibodies and reviewing available evidence before purchase.
Pro Tip: When antibody stock is limited, run a micro-titration series in small-volume steps rather than full dilutions, so a single vial can answer several optimisation questions.
5. Why validation-first selection reduces wasted experiments
A pattern we have observed repeatedly is that time spent confirming an antibody’s identity before a full experimental run saves far more time than it costs. A failed blot discovered after weeks of treatment conditions is a heavier loss than an afternoon of titration. Logging validation data, sharing it with colleagues, and treating antibody choice as part of experimental design rather than an afterthought tends to pay for itself across a project.
— Veron
How ABMIUM supports antibody selection and validation
We list a curated Primary Antibodies collection filtered by application, species and available validation evidence, which shortens the search for a WB-suitable reagent. 
When a target proves difficult to validate in-house, our ABMIUM MATCH™ service pairs researchers with scientist-led sourcing support to compare candidate antibodies and their supporting evidence before purchase.
FAQ
How should I choose antibodies for a Western blot?
Start by confirming the antibody carries documented WB validation, then match host species and isotype to your sample and secondary antibody. Favour monoclonal or recombinant formats when reproducibility across batches matters, and confirm epitope accessibility suits denatured protein on SDS-PAGE.
How much antibody is needed for a Western blot?
The correct amount depends on the specific antibody and target abundance, so a micro-titration series run in small steps is the most reliable way to find it. This approach also conserves limited stock, since serial dilutions can be tested in small volumes before committing to a working dilution.
What antibodies are used in Western blot?
Western blot typically uses an unconjugated or conjugated primary antibody against the target protein, often paired with a species-matched secondary antibody carrying an enzyme or fluorophore for detection. A loading control antibody, commonly against beta-actin, GAPDH or tubulin, is frequently included to confirm equal sample loading, though total protein staining is an increasingly used alternative.
Do you need a secondary antibody for a Western blot?
A secondary antibody is needed whenever the primary antibody is unconjugated, since it carries the enzyme or fluorophore used for detection. Directly conjugated primary antibodies skip this step, which can simplify multiplex panels but generally trades away some signal sensitivity.
Sources
- Antibody selection and validation considerations (PMC6983856)
- Review: total protein staining as loading control (PubMed 28941183)
- A consensus platform for antibody characterization (Nature Protocols, 2024)